Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Bleomycin Use in the Treatment of Hodgkin Lymphoma (HL): Toxicity and Outcomes in the Modern Era

Kekoa Taparra, PhD, Heshan Liu, PhD, Mei-Yin Polley, PhD, Kay M. Ristow, BS, Thomas M. Habermann, MD, Stephen M Ansell, MD PhD

Blood (2019) 134 (Supplement_1): 4038.

https://doi.org/10.1182/blood-2019-121488

Published: 2019

Journal Articles

Clinical Features and Treatment for Neurolymphomatosis in the Rituximab Era: Single Institution Experience

Mattia Novo, Grzegorz Nowakowski, MD, Ivana Micallef, MD, Rebecca L. King, MD, Robert Spinner, MD, Kay M. Ristow, BS, Thomas M. Habermann, MD, Patrick Johnston, MD PhD

Blood (2019) 134 (Supplement_1): 4129.

https://doi.org/10.1182/blood-2019-131378

Published: 2019

Journal Articles

Characteristics, Treatment Patterns, and Outcomes in Primary Cutaneous Gamma Delta T Cell Lymphoma (PCGDTCL): A Real World Multi-Institutional Analysis of a Rare Malignancy

Blood (2019) 134 (Supplement_1): 4028.

https://doi.org/10.1182/blood-2019-130223

Published: 2019

Journal Articles

Central Nervous System Involvement in Peripheral T-Cell Lymphoma

Sangeetha Gandhi, MBBS, N. Nora Bennani, MD, Sonia Fortin, Thomas M. Habermann, MD, Patrick Johnston, MD, James R. Cerhan, MD PhD, Kay M. Ristow, BS, Carrie A. Thompson, MD, Grzegorz Nowakowski, MD, Yi Lin, MD PhD, Jose C Villasboas, MD, Luis Porrata, MD, Thomas E. Witzig, MD, Ivana Micallef, MD, David J Inwards, MD, Stephen M Ansell, MD PhD, Jonas Paludo, MD

Blood (2019) 134 (Supplement_1): 5293.

https://doi.org/10.1182/blood-2019-131965

Published: 2019

Journal Articles

Clinical Characteristics and Outcomes of an Analysis of a Single Institution Experience of the 2017 World Health Organization (WHO) Classification of Post-Transplant Lymphoproliferative Disorders (PTLD)

Thomas M. Habermann, MD, Angelo Fama, MD, Kay M. Ristow, BS, Matthew J. Maurer, MS, William R. Macon, MD, Stephen M. Ansell, MD PhD, Nabila Nora Bennani, MD, Yogish C Kudva, MBBS, Randall C. Walker, MD, Kimberly D. Watt, Thomas R. Schwab, MD, James R. Cerhan, MD PhD, Rebecca L King, MD

Blood (2018) 132 (Supplement 1): 456.

https://doi.org/10.1182/blood-2018-99-113667

Published: 2018

Journal Articles

Non-Diffuse Large B-Cell Primary Central Nervous System Lymphoma

Sangeetha Gandhi, MBBS, Grzegorz S. Nowakowski, MD, Thomas M. Habermann, MD, Kay M. Ristow, BS, Patrick Johnston

Blood (2018) 132 (Supplement 1): 4208.

https://doi.org/10.1182/blood-2018-99-119741

Published: 2018

Journal Articles

Lenalidomide in Combination with Standard R-CHOP Overcomes the Negative Prognostic Value of Peripheral Blood Absolute Lymphocyte/Monocyte Ratio at Diagnosis and during Treatment in Patients with Diffuse Large B-Cell Lymphoma

Alessia Castellino, MD, Levy D. Pederson, Kay M. Ristow, BS, Christina Stenzel, Betsy Laplant, MS, Thomas E. Witzig, MD, Thomas M. Habermann, MD, Grzegorz S. Nowakowski, MD, Luis Porrata, MD

Blood (2018) 132 (Supplement 1): 4139.

https://doi.org/10.1182/blood-2018-99-114010

Published: 2018

Journal Articles

Role of Systemic High-Dose Methotrexate and Combined Approaches in the Management of Vitreoretinal Diffuse Large B-Cell Lymphoma: A Single Center Experience 1990-2018

Alessia Castellino, MD, Jose Pulido, PhD, Patrick Johnston, Kay M. Ristow, BS, Nabila Nora Bennani, MD, David J Inwards, MD, William R. Macon, MD, Ivana N Micallef, MD, Rebecca L King, MD, Diva Salomao, MD, Thomas E. Witzig, MD, Thomas M. Habermann, MD, Grzegorz Nowakowski, MD

Blood (2018) 132 (Supplement 1): 574.

https://doi.org/10.1182/blood-2018-99-113826

Published: 2018

Journal Articles

Epstein-Barr Virus Status in Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder

Angelo Fama, MD, Rebecca L King, MD, Matthew J. Maurer, MS, Kay M. Ristow, BS, William R Macon, MD, Stephen M Ansell, MD, Nora N Bennani, MD, Randall C. Walker, MD, Yogish C Kudva, MBBS, Kymberly D Watt, MD, Thomas R. Schwab, MD, James R. Cerhan, MD PhD, Grzegorz S. Nowakowski, MD, Thomas M. Habermann, MD

Blood (2018) 132 (Supplement 1): 2979.

https://doi.org/10.1182/blood-2018-99-116738

Published: 2018

Journal Articles

Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution

Saad Sirop Kenderian, Thomas M. Habermann, William R. Macon, Kay M. Ristow, Stephen M. Ansell, Joseph P. Colgan, Patrick B. Johnston, David J. Inwards, Svetomir N. Markovic, Ivana N. Micallef, Carrie A. Thompson, Luis F. Porrata, James A. Martenson, Thomas E. Witzig, Grzegorz S. Nowakowski

Blood (2016) 127 (16): 1960–1966.

https://doi.org/10.1182/blood-2015-08-665505

Published: 2016

Journal Articles

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) of the Salivary Gland Is Associated with Improved Prognosis When Arising in a Background of Sjögren’s Disease and May Not Benefit from Local Therapy

Amie E Jackson, MD, Michael Mian, Christina H. Kalpadakis, MD, Gerassimos A Pangalis, MD, Anastasios Stathis, MD, Elena Porro, MSc, Ellen D McPhail, MD, Thomas M Habermann, MD, Kay M. Ristow, Franco Cavalli, MD, Grzegorz S. Nowakowski, MD, Emanuele Zucca, MD

Blood (2014) 124 (21): 1637.

https://doi.org/10.1182/blood.V124.21.1637.1637

Published: 2014

Journal Articles

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

Blood (2014) 124 (9): 1473–1480.

https://doi.org/10.1182/blood-2014-04-571091

Published: 2014

Includes: Supplemental data

Journal Articles

Peripheral Blood Absolute Lymphocyte/Monocyte Ratio Recovery During RCHOP Treatment Cycles Predicts Clinical Outcomes In Diffuse Large B-Cell Lymphoma

Luis F. Porrata, MD, Kay M. Ristow, Thomas M Habermann, MD, Thomas E Witzig, MD, Joseph P. Colgan, MD, David J. Inwards, MD, Stephen M Ansell, M.D. Ph.D., Ivana N. Micallef, MD, Patrick B. Johnston, MD, PhD, Grzegorz S. Nowakowski, MD, Carrie A Thompson, MD, Svetomir N. Markovic, MD, PhD

Blood (2013) 122 (21): 4306.

https://doi.org/10.1182/blood.V122.21.4306.4306

Published: 2013

Journal Articles

GATA-3 Expression Promotes IL-10 Production, Alternative Macrophage Polarization, and Identifies a Subset Of High-Risk PTCL, NOS

Tianjiao Wang, Ph.D., Andrew L. Feldman, David A Wada, MD, Ye Lu, MD, Avery Polk, BS, Robert Briski, BS, Kay M. Ristow, Thomas M Habermann, MD, Dafydd G Thomas, MD/Ph.D., Steven C. Ziesmer, Linda E Wellik, Thomas Lanigan, Ph.D., Thomas E Witzig, MD, Mark Pittelkow, MD, Nathanael G. Bailey, MD, Megan Lim, MD, PhD, Stephen M Ansell, M.D.Ph.D., Ryan A. Wilcox, MD, PhD

Blood (2013) 122 (21): 841.

https://doi.org/10.1182/blood.V122.21.841.841

Published: 2013

Journal Articles

Diffuse Large B-Cell Transformation in Nodular Lymphocyte Predominant Hodgkin Lymphoma: Incidence, Risk Factors and Outcomes After a Forty-Year Experience From a Single Institution

Saad J. Sirop, MD, Thomas M Habermann, MD, William R Macon, MD, Kay M. Ristow, Stephen M Ansell, MD, PhD, Joseph P Colgan, MD, Patrick B. Johnston, MD, PhD, David J. Inwards, MD, Svetomir N. Markovic, MD, PhD, Ivana N. Micallef, MD, Carrie Thompson, MD, Luis F. Porrata, MD, James A. Martenson, Jr., MD, James R Cerhan, MD, PhD, Thomas E. Witzig, MD, Grzegorz S. Nowakowski, MD

Blood (2012) 120 (21): 1525.

https://doi.org/10.1182/blood.V120.21.1525.1525

Published: 2012

Journal Articles

Peripheral Blood Absolute Lymphocyte/Monocyte Ratio At Diagnosis Is Independent of the Interim Positron-Emission Tomography in Predicting Progression-Free Survival and Time to Progression in Classical Hodgkin Lymphoma (HL)

Luis F. Porrata, MD, Kay M. Ristow, Thomas M. Habermann, Thomas E Witzig, Joseph P. Colgan, MD, David J. Inwards, MD, Stephen M. Ansell, M.D., Ph.D., Ivana N. Micallef, MD, Patrick B. Johnston, MD, PhD, Grzegorz S. Nowakowski, MD, Carrie A. Thompson, MD, Svetomir N. Markovic, MD, PhD

Blood (2012) 120 (21): 1527.

https://doi.org/10.1182/blood.V120.21.1527.1527

Published: 2012

Journal Articles

Peripheral Blood Absolute Lymphocyte/Monocyte Ratio Recovery During ABVD Treatment Cycles Predicts Clinical Outcomes in Classical Hodgkin Lymphoma (HL).

Luis F. Porrata, MD, Kay M. Ristow, Thomas M Habermann, MD, Thomas E. Witzig, MD, Joseph P. Colgan, MD, David J. Inwards, MD, Stephen M Ansell, M.D., Ph.D., Ivana N. Micallef, MD, Patrick B. Johnston, MD, PhD, Grzegorz S. Nowakowski, MD, Carrie A. Thompson, MD, Svetomir N. Markovic, MD, PhD

Blood (2012) 120 (21): 2634.

https://doi.org/10.1182/blood.V120.21.2634.2634

Published: 2012

Journal Articles

The Presence of Intratumoral CD14 Positive Cells Is Associated with Transformation of Follicular Lymphoma to Diffuse Large B Cell Lymphoma.

Jason M. Jones, MD, Ahmet Dogan, MD, PhD, Steven C. Ziesmer, Grzegorz S. Nowakowski, MD, Kay M. Ristow, Zhi-Zhang Yang, MD, James R Cerhan, MD, PhD, Stephen M. Ansell, M.D., Ph.D.

Blood (2012) 120 (21): 2700.

https://doi.org/10.1182/blood.V120.21.2700.2700

Published: 2012

Journal Articles

Risk of Transformation of Follicular Lymphoma to High Grade Lymphoma After Radioimmunotherapy: A Prospective Observational Single Institutional Experience

Brian L. Burnette, MD, Gregory Wiseman, MD, Thomas M. Habermann, MD, William R Macon, MD, Stephen M. Ansell, MD, PhD, David James Inwards, MD, Ivana N. Micallef, MD, Patrick B. Johnston, Kay M. Ristow, Thomas E. Witzig, MD, Grzegorz S. Nowakowski, MD

Blood (2011) 118 (21): 1572.

https://doi.org/10.1182/blood.V118.21.1572.1572

Published: 2011

Journal Articles

Primary Parotid MALT Lymphoma: Clinical Characteristics and Treatment – a Single Institution Experience

Jason M. Jones, MD, Thomas M. Habermann, MD, Kay M. Ristow, Paul Kurtin, MD, Ellen McPhail, MD, Carrie A. Thompson, MD, Joseph P. Colgan, MD, Luis F. Porrata, MD, Svetomir N. Markovic, MD, PhD, Thomas E. Witzig, MD, James A. Martenson, Jr., MD, Grzegorz S. Nowakowski, MD

Blood (2011) 118 (21): 1580.

https://doi.org/10.1182/blood.V118.21.1580.1580

Published: 2011

NARROW

Bleomycin Use in the Treatment of Hodgkin Lymphoma (HL): Toxicity and Outcomes in the Modern Era

Clinical Features and Treatment for Neurolymphomatosis in the Rituximab Era: Single Institution Experience

Characteristics, Treatment Patterns, and Outcomes in Primary Cutaneous Gamma Delta T Cell Lymphoma (PCGDTCL): A Real World Multi-Institutional Analysis of a Rare Malignancy

Central Nervous System Involvement in Peripheral T-Cell Lymphoma

Clinical Characteristics and Outcomes of an Analysis of a Single Institution Experience of the 2017 World Health Organization (WHO) Classification of Post-Transplant Lymphoproliferative Disorders (PTLD)

Non-Diffuse Large B-Cell Primary Central Nervous System Lymphoma

Lenalidomide in Combination with Standard R-CHOP Overcomes the Negative Prognostic Value of Peripheral Blood Absolute Lymphocyte/Monocyte Ratio at Diagnosis and during Treatment in Patients with Diffuse Large B-Cell Lymphoma

Role of Systemic High-Dose Methotrexate and Combined Approaches in the Management of Vitreoretinal Diffuse Large B-Cell Lymphoma: A Single Center Experience 1990-2018

Epstein-Barr Virus Status in Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder

Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) of the Salivary Gland Is Associated with Improved Prognosis When Arising in a Background of Sjögren’s Disease and May Not Benefit from Local Therapy

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

Peripheral Blood Absolute Lymphocyte/Monocyte Ratio Recovery During RCHOP Treatment Cycles Predicts Clinical Outcomes In Diffuse Large B-Cell Lymphoma

GATA-3 Expression Promotes IL-10 Production, Alternative Macrophage Polarization, and Identifies a Subset Of High-Risk PTCL, NOS

Diffuse Large B-Cell Transformation in Nodular Lymphocyte Predominant Hodgkin Lymphoma: Incidence, Risk Factors and Outcomes After a Forty-Year Experience From a Single Institution

Peripheral Blood Absolute Lymphocyte/Monocyte Ratio At Diagnosis Is Independent of the Interim Positron-Emission Tomography in Predicting Progression-Free Survival and Time to Progression in Classical Hodgkin Lymphoma (HL)

Peripheral Blood Absolute Lymphocyte/Monocyte Ratio Recovery During ABVD Treatment Cycles Predicts Clinical Outcomes in Classical Hodgkin Lymphoma (HL).

The Presence of Intratumoral CD14 Positive Cells Is Associated with Transformation of Follicular Lymphoma to Diffuse Large B Cell Lymphoma.

Risk of Transformation of Follicular Lymphoma to High Grade Lymphoma After Radioimmunotherapy: A Prospective Observational Single Institutional Experience

Primary Parotid MALT Lymphoma: Clinical Characteristics and Treatment – a Single Institution Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only